PhcogMag 20 3 863
Ravi Pratap Singh1, Ashok Kumar Pattnaik1★★ Corresponding author
- 1Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, INDIA.
CORRESPONDENCE
Ashok Kumar Pattnaik
Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, INDIA.
Received: 04-10-2023; Accepted: 18-12-2023.
Volume 20, Issue 3 · pp. 863–876 · PUBLISHED 2024 · DOI: 10.1177/09731296241228925
View on Pharmacogn. Mag. original site ↗
ABSTRACT
Background: Hyperlipidemia is a common precursor to cardiovascular diseases, necessitating effective intervention. This study explores the potential of a bioactive fraction derived from Kalanchoe pinnata leaf, a less-explored natural source, for its antihyperlipidemic properties. Objectives: The primary objectives of this research are to isolate and assess the bioactive fraction from Kalanchoe pinnata leaves extract for its antihyperlipidemic attributes using a murine model. The study also aims to characterize the fraction and investigate its interactions with hyperlipidemia-related proteins. Materials and Methods: Kalanchoe pinnata leaves were extracted and fractionated via flash chromatography. Isolated fractions underwent phytochemical, antioxidant, and enzyme inhibition assays in vitro. In vivo, selected fractions were tested in Triton WR-1339-induced hyperlipidemic mice. Fraction F2, which exhibits the most potent activity, was characterized using HPTLC MS/MSn chromatography. Molecular docking studies explored interactions between F2 compounds and hyperlipidemia-related proteins. Results: Fraction F2 displayed significant in vivo antihyperlipidemic activity, with observable morphological changes in mice. HPTLC MS/MSn identified four major compounds in F2, while docking studies revealed potential interactions with hyperlipidemia-related proteins. Conclusion: This study underscores F2’s potential as a potent antihyperlipidemic agent sourced from Kalanchoe pinnata leaves. The identified compounds hold promise for further research in hyperlipidemia therapy development, emphasizing the therapeutic potential of natural Kalanchoe pinnata compounds for managing hyperlipidemia and related cardiovascular conditions.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Singh, R. P., & Pattnaik, A. K. (2024). PhcogMag 20 3 863. Pharmacognosy Magazine, 20(3), 863–876. https://doi.org/10.1177/09731296241228925